Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health
Elanco Announces USDA Approval of TruCan Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs
Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World Screwworm
New Research Reveals Pet Spending as a "Protected Budget Item" for Owners, Fueling Industry Resilience
Elanco Launches Befrena , New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market
Elanco's Negasunt Powder and Tanidil Receive Emergency Authorization for Use Against New World Screwworm in Livestock
Elanco Launches Advantage Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes*
Elanco Launches Advantage Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes*
Star Copper Extends Copper Creek Drill Hole Beyond Planned Depth After Intersecting Mineralized System
Westport Announces US$10 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
